ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

DeVita Dissatisfied With Cooperative Groups on Accrual; NCAB to Hear Wittes’ Plan In Feb.

November 20, 1987

ACCC Preliminary Report on DRGs Finds Case Mix Can Alter Profit/ Loss Pictures

March 29, 1985

CTEP-Approved Trials For the Month of June

June 28, 2013

Shingleton Nominated To President’s Panel

June 10, 1977

NCCS Networker Volume 9 Issue 2, Summer 1995

June 13, 1995